CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 128 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $39,000 | -11.4% | 14,530 | +42.3% | 0.00% | – |
| Q4 2021 | $44,000 | -72.0% | 10,209 | -66.9% | 0.00% | -100.0% |
| Q3 2021 | $157,000 | +115.1% | 30,846 | +166.5% | 0.00% | – |
| Q2 2021 | $73,000 | -29.8% | 11,574 | -14.1% | 0.00% | -100.0% |
| Q1 2021 | $104,000 | -28.3% | 13,476 | -38.2% | 0.00% | 0.0% |
| Q3 2020 | $145,000 | +43.6% | 21,797 | +80.2% | 0.00% | 0.0% |
| Q2 2020 | $101,000 | -24.1% | 12,098 | -30.3% | 0.00% | 0.0% |
| Q1 2020 | $133,000 | +11.8% | 17,355 | +233.8% | 0.00% | 0.0% |
| Q2 2018 | $119,000 | +1.7% | 5,200 | -30.5% | 0.00% | 0.0% |
| Q3 2016 | $117,000 | – | 7,478 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |